Enter the first few characters of Company and click 'Go'

Oxygenta Pharmaceutical Ltd. Company History and Annual Growth Details

OXYGENTA PHARMACEUTICAL LIMITED was incorporated as Private Limited Company in the year 1990 and subsequently converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.

1990 - The company was incorporated and its main line of business was bulk drugs.

1994 - The company had entered into an MOU with ICD group BV of Netherlands. As per the agreement, ICD would purchase 36 tonnes a year of mebadazole and 12 tonnes of atenolol for a period of five years from the company.

1998 - The company was turned sick and was registered with BIFR.

2003

-The board of the company had approved to convert the unsecured loans of Rs 2 crore into 20 lakh equity shares of Rs 10 each.

- The board had also proposed to increase the authorized capital to Rs 8 crore from the existing level of Rs 6 crore.

2006

- Mr. Y Ramachandra Reddy (joint managing director), Mr. E Rama Subba Reddy (director) and Mr. G Chandramoulieswar Reddy (director) had resigned from the board of directors of the company.

2007

- Board of directors of the company on 4th April had passed the resolution to extend the financial year of the company to 15 months.

2008

- The Board of the company had appointed Mr. MG Naidu as independent director of the company.

2022

-Company name has changed to Oxygenta Pharmaceutical Ltd. from S S Organics Ltd..

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article